Posts in Company news

by gene001web
September 1, 2023

GeneTether Therapeutics Inc. Announces Second Quarter 2023 Financial Results

Vancouver, British Columbia – August 25, 2023
0
read more
by gene001web
June 12, 2023

GeneTether Therapeutics Inc. Announces First Quarter 2023 Financial Results and Provides Corporate Update

Vancouver, British Columbia – May 25, 2023
0
read more
by gene001web
May 2, 2023

GeneTether Therapeutics Engages Gad Berdugo, Managing Partner of Explorium Capital LLC, as Advisor to Explore Strategic Alternatives for GeneTether Technology Platform

Vancouver, British Columbia – May 1st, 2023
0
read more
by gene001web
May 2, 2023

GeneTether Therapeutics Inc. Announces Fiscal Year 2022 Financial Results and Reports on Corporate Highlights

Vancouver, British Columbia – April 27, 2023
0
read more
by gene001web
March 31, 2023

GeneTether Therapeutics Inc. Update – From the Desk of the CEO

Vancouver, British Columbia – March 30, 2023
0
read more
by gene001web
February 9, 2023

GeneTether Therapeutics Inc. Announces Commencement of Strategic Review Process

Vancouver, British Columbia – February 08, 2023
0
read more
by gene001web
November 29, 2022

GeneTether Therapeutics Inc. Announces Third Quarter 2022 Financial Results and Reports on Corporate Highlights

Vancouver, British Columbia – November 25, 2022
0
read more
by gene001web
October 26, 2022

GeneTether Therapeutics Inc. Update – From the Desk of the CEO

Vancouver, British Columbia – October 25, 2022
0
read more
by gene001web
August 25, 2022

GeneTether Therapeutics Inc. Announces Second Quarter 2022 Financial Results and Reports on Corporate Highlights

Vancouver, British Columbia – August 24, 2022
0
read more
by gene001web
May 27, 2022

GeneTether Therapeutics Announces Issuance of New US Composition of Matter Patent for its Innovative Platform Technology Focused on Gene Editing Efficiency

San Lorenzo, California and Vancouver, British Columbia – May 25, 2022
0
read more